Diagnostics & Research
The Diagnostics & Research industry has a total of 50 stocks, with a combined market cap of $777.99 billion, total revenue of $166.47 billion and a weighted average PE ratio of 52.02.
Market Cap
777.99B
Revenue
166.47B
Profits
14.96B
PE Ratio
52.02
Profit Margin
8.98%
Dividend Yield
0.18%
50 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 211.55B | -0.90% | 1,416,016 | 43.74B |
| 2 | DHR | Danaher Corporation | 157.68B | -0.56% | 3,369,194 | 24.27B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 55.82B | -1.07% | 409,302 | 4.17B |
| 4 | A | Agilent Technologies, Inc. | 39.81B | -1.26% | 2,324,485 | 6.95B |
| 5 | IQV | IQVIA Holdings Inc. | 37.14B | -2.46% | 1,185,496 | 15.90B |
| 6 | NTRA | Natera, Inc. | 32.51B | -1.51% | 1,082,252 | 2.12B |
| 7 | MTD | Mettler-Toledo International Inc. | 28.02B | -0.72% | 113,692 | 3.94B |
| 8 | WAT | Waters Corporation | 22.99B | -1.68% | 413,862 | 3.11B |
| 9 | LH | Labcorp Holdings Inc. | 21.39B | -0.72% | 500,199 | 13.77B |
| 10 | ILMN | Illumina, Inc. | 20.19B | 3.83% | 3,246,110 | 4.29B |
| 11 | DGX | Quest Diagnostics Incorporated | 19.98B | -1.21% | 846,482 | 10.85B |
| 12 | EXAS | Exact Sciences Corporation | 19.21B | 0.29% | 2,933,159 | 3.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 15.33B | -0.93% | 210,303 | 2.36B |
| 14 | ICLR | ICON Public Limited Company | 13.84B | -0.44% | 629,615 | 8.10B |
| 15 | GH | Guardant Health, Inc. | 13.30B | -0.92% | 1,424,937 | 902.57M |
| 16 | RVTY | Revvity, Inc. | 11.20B | -1.01% | 886,269 | 2.81B |
| 17 | QGEN | Qiagen N.V. | 9.88B | -0.65% | 855,666 | 2.07B |
| 18 | CRL | Charles River Laboratories International, Inc. | 9.15B | -0.60% | 1,070,104 | 4.02B |
| 19 | RDNT | RadNet, Inc. | 5.85B | -0.41% | 810,629 | 1.97B |
| 20 | BLLN | BillionToOne, Inc. | 4.97B | 4.65% | 203,115 | 254.14M |
| 21 | SHC | Sotera Health Company | 4.75B | 0.63% | 2,680,387 | 1.15B |
| 22 | WGS | GeneDx Holdings Corp. | 4.65B | 0.64% | 302,554 | 402.19M |
| 23 | GRAL | GRAIL, Inc. | 3.80B | -2.34% | 906,572 | 141.83M |
| 24 | VCYT | Veracyte, Inc. | 3.47B | -1.17% | 892,770 | 495.14M |
| 25 | TWST | Twist Bioscience Corporation | 1.93B | -1.99% | 900,473 | 376.57M |
| 26 | NEO | NeoGenomics, Inc. | 1.53B | 0.77% | 1,440,608 | 709.16M |
| 27 | NEOG | Neogen Corporation | 1.39B | 5.96% | 6,816,737 | 886.89M |
| 28 | CSTL | Castle Biosciences, Inc. | 1.12B | 0.39% | 514,077 | 343.53M |
| 29 | OPK | OPKO Health, Inc. | 1.04B | 3.03% | 3,561,779 | 642.07M |
| 30 | CDNA | CareDx, Inc | 990.08M | 1.85% | 827,603 | 358.00M |
| 31 | FLGT | Fulgent Genetics, Inc. | 848.85M | -1.44% | 194,244 | 315.55M |
| 32 | PSNL | Personalis, Inc. | 822.33M | -5.70% | 1,040,883 | 69.10M |
| 33 | MYGN | Myriad Genetics, Inc. | 685.12M | 3.96% | 1,128,170 | 825.30M |
| 34 | PRE | Prenetics Global Limited | 236.19M | -1.99% | 137,040 | 77.08M |
| 35 | BNR | Burning Rock Biotech Limited | 169.25M | -13.63% | 60,468 | 75.75M |
| 36 | MDXH | MDxHealth SA | 165.82M | -4.56% | 322,879 | 103.07M |
| 37 | XGN | Exagen Inc. | 159.09M | 0.43% | 267,633 | 63.60M |
| 38 | IMDX | Insight Molecular Diagnostics Inc. | 147.62M | 4.25% | 24,840 | 4.40M |
| 39 | FONR | FONAR Corporation | 93.36M | -0.49% | 28,782 | 105.43M |
| 40 | BDSX | Biodesix, Inc. | 66.19M | 6.80% | 51,313 | 80.17M |
| 41 | PRPO | Precipio, Inc. | 42.84M | -1.65% | 7,411 | 22.80M |
| 42 | NOTV | Inotiv, Inc. | 29.19M | 2.33% | 262,080 | 513.02M |
| 43 | MBAI | Check-Cap Ltd. | 10.47M | 4.68% | 57,303 | - |
| 44 | ADVB | Advanced Biomed Inc. | 7.93M | 1.27% | 6,795,297 | - |
| 45 | BIAF | bioAffinity Technologies, Inc. | 7.46M | 0.61% | 63,076 | 6.78M |
| 46 | PRPH | ProPhase Labs, Inc. | 6.88M | 7.97% | 3,033,922 | 5.06M |
| 47 | NDRA | ENDRA Life Sciences Inc. | 6.77M | 5.84% | 721,458 | - |
| 48 | MYNZ | Mainz Biomed N.V. | 5.74M | -1.85% | 83,265 | 659.94K |
| 49 | ISPC | iSpecimen Inc. | 4.97M | 6.04% | 236,609 | 3.35M |
| 50 | XWEL | XWELL, Inc. | 4.50M | -1.28% | 12,789 | 29.52M |